- About Us
- About Ovarian Cancer
- Research & Grants
- Resources
- News
- Tributes
- Events
- Partners
Ovarian cancer, the deadliest of all gynecologic cancers, has provided a significant challenge for the scientific community. While survival rates for other women’s cancers – like breast and cervical cancer – have increased dramatically in recent years, the incidence and mortality of ovarian cancer has remained unchanged in 50 years. This is primarily due to the lack of an accurate early detection test for the disease.
When caught in its earliest stages, ovarian cancer survival rates can be as high as 90 percent. Regrettably, however, early symptoms of ovarian cancer are difficult to diagnose, are often misdiagnosed, or go undetected, which leads to nearly 75% of all ovarian cancer patients being diagnosed in advanced stages. Long-term survival rate for advanced ovarian cancer is only 10%.